![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 11,271 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS Number:2477L Celsis International PLC 07 January 2008 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Celsis International Plc 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: Barclays PLC 4. Full name of shareholder(s) (if different from 3.): Barclays Global Investors Ltd Barclays Life Assurance Co Ltd Barclays Stockbrokers Ltd Gerrard Investment Management Ltd 5. Date of the transaction and date on which the threshold is crossed or reached if different): 20-Dec-07 6. Date on which issuer notified: 24-Dec-07 7. Threshold(s) that is/are crossed or reached: 10% to 5% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to the Triggering if possible using the transaction ISIN CODE Number of shares Number of voting Rights GB00B0CD5F69 2,356,451 2,356,451 Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible using the ISIN CODE Direct Indirect Direct Indirect GB00B0CD5F69 1,248,249 0 1,248,249 0.00 5.65 B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting % of voting financial Period/ Date rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 1,248,249 5.65 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Barclays Global Investors Ltd Barclays Life Assurance Co Ltd Barclays Stockbrokers Ltd Gerrard Investment Management Ltd Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: Geoff Smith 15. Contact telephone number: 020 7116 2913 This information is provided by RNS The company news service from the London Stock Exchange END HOLUBRNRWKRARAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions